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Introduction
Tissue repair after damage is an evolutionary conserved process 
in which interactions between infiltrating inflammatory cells 
and resident stem cells must be finely coordinated if tissue in-
tegrity and homeostasis are to be restored. Perturbation of these 
interactions leads to unsuccessful healing (Gurtner et al., 2008; 
Eming et al., 2009; Soehnlein and Lindbom, 2010). Nonethe-
less, little is known about the molecular mechanisms control-
ling timely and efficient tissue repair.
Skeletal muscle regeneration after injury exemplifies the 
careful orchestration of inflammatory and tissue-specific stem 
cell responses. Macrophages are the major infiltrating inflam-
matory cells in damaged muscle and play an integral role in the 
successful healing process. At early stages after injury, macro-
phages phagocytose necrotic myofiber debris and provide the ini-
tial signals to activate muscle stem cell (satellite cell)–dependent 
tissue regeneration (Eming et al., 2009). Subsequently, the pro-
cess of inflammation resolution requires specialized subsets of 
immune cells, such as antiinflammatory and alternatively acti-
vated macrophages, that have specific functional characteristics 
related to suppressing the initial proinflammatory response and 
promoting egress of inflammatory cells and the final stages of tis-
sue replacement. Recent studies showed that infiltrating macro-
phages change their initial proinflammatory activation state (M1) 
to an antiinflammatory one (M2) during muscle regeneration 
R
epair of damaged tissue requires the coordinated 
action of inflammatory and tissue-specific cells to 
restore homeostasis, but the underlying regulatory 
mechanisms  are  poorly  understood.  In  this  paper,  we   
report  new  roles  for  MKP-1  (mitogen-activated  protein   
kinase [MAPK] phosphatase-1) in controlling macrophage 
phenotypic transitions necessary for appropriate mus-
cle stem cell–dependent tissue repair. By restricting p38 
MAPK activation, MKP-1 allows the early pro- to anti-
inflammatory macrophage transition and the later progres-
sion into a macrophage exhaustion-like state characterized 
by cytokine silencing, thereby permitting resolution of in-
flammation as tissue fully recovers. p38 hyperactivation in 
macrophages lacking MKP-1 induced the expression of 
microRNA-21 (miR-21), which in turn reduced PTEN 
(phosphatase  and  tensin  homologue)  levels,  thereby 
extending AKT activation. In the absence of MKP-1, p38-
induced AKT activity anticipated the acquisition of the 
antiinflammatory gene program and final cytokine si-
lencing in macrophages, resulting in impaired tissue heal-
ing. Such defects were reversed by temporally controlled 
p38 inhibition. Conversely, miR-21–AKT interference al-
tered homeostasis during tissue repair. This novel regula-
tory  mechanism  involving  the  appropriate  balance  of 
p38, MKP-1, miR-21, and AKT activities may have impli-
cations in chronic inflammatory degenerative diseases.
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(Kokkola et al., 2005; Bianchi and Manfredi, 2007; Zhang and 
Mosser, 2008). The magnitude and duration of inflammation 
and, hence, of the linked MAPK activation state need to be 
tightly controlled because unrestrained inflammation underlies 
diverse forms of chronic diseases (Fukata et al., 2009). MKP-1   
(MAPK  phosphatase-1;  archetype  member  of  the  MAPK 
phosphatase/dual specificity phosphatase family) controls the 
threshold  and  magnitude  of  MAPK  activation  by  reversing 
MAPK phosphorylation (predominantly p38 MAPK; Wang and 
Liu, 2007; Li et al., 2009). Interestingly, MAPKs are known 
to induce MKP-1 gene transcription via a negative feedback 
loop as part of the induction of the antiinflammatory response 
to bacterial infection (Li et al., 2001). This regulatory action 
seems also to account for the proposed positive and negative 
effects of MKP-1 on adipose and myogenic cells, as shown by 
(Arnold et al., 2007; Ruffell et al., 2009). Perturbation of the 
timing or specification of the inflammatory response can lead to 
aberrant regeneration and pathological conditions, for example, 
the persistence of macrophages in dystrophic muscle is thought 
to contribute to disease progression (Tidball, 2005; Vidal et al., 
2008; Villalta et al., 2009). However, the molecular regulators 
of the discrete macrophage activation phenotypes remain prac-
tically unknown.
MAPKs are central regulators of inflammatory responses 
to exogenous (i.e., infections) and endogenous (tissue injury) 
insults (Kim et al., 2008; Coulthard et al., 2009). JNK, p38, 
and extracellular signal-related kinase MAPKs are rapidly ac-
tivated in response to bacterial endotoxins or damaged tissue– 
released factors, such as HMGB1 (high-mobility group protein B1),   
to induce proinflammatory mediators by inflammatory cells 
Figure 1.  p38–MKP-1 balance is required for 
efficient skeletal muscle repair. (A) Number of 
F4/80-positive macrophages in WT muscle at 
the indicated times postinjury (P.I.) that were ob-
tained by flow cytometry. Total number of cells 
per milligram of CTX-injured muscle tissue was 
calculated.  (B)  Phospho-p38–  and  phospho– 
c-Jun (as an indicator of activated JNK)–positive 
macrophages (P-p38 and P-cJun, respectively) 
were counted in immunostained cryosections 
of gastrocnemius muscles obtained from WT 
mice 3, 6, and 10 d after injury (see pictures 
in Fig. S1 C). (C) Gene expression analysis by 
RT-PCR in isolated macrophage populations at 
the indicated times after injury. (D) As in A, 
number of F4/80-positive macrophages in WT 
and MKP-1
/ mice per milligram of injured 
muscle tissue. (E) As in B, phospho-p38– and 
phospho–c-Jun–positive macrophages from WT 
and MKP-1
/ mice at the indicated times after 
injury (see pictures in Fig. S1 C). (F) Muscle 
cryosections were stained with an anti-eMHC 
antibody. Bar, 50 µm. (G) As in F, cryosections 
were stained with H/E, and the mean area of 
regenerating  myofibers  was  calculated  (see 
pictures in Fig. S1). Means ± SEM of at least   
three experiments.  ***,  P  <  0.001;  **,  P  <  0.01;   
*, P < 0.05.309 MKP-1–p38 controls inflammation-mediated tissue repair • Perdiguero et al.
gain- and loss-of-function studies in vitro and in vivo (Bennett 
and Tonks, 1997; Wu et al., 2006; Roth et al., 2009; Shi et al., 
2010). Similarly, increases in TNF, IL-6 (interleukin-6), and 
IL-10 (interleukin-10) expression dependent on p38 activation, 
concomitant with enhanced induced NO synthase–NO and re-
duced arginase synthesis, have been proposed to underlie the 
exacerbated response to endotoxin challenge in mice geneti-
cally deficient in MKP-1 (Chi et al., 2006; Hammer et al., 2006; 
Wu et al., 2006; Zhao et al., 2006). Contrarily to the known 
role of MPK-1 on the inflammatory response to bacterial infec-
tion, its function in the control of macrophage transitions during   
tissue healing, from the initial inflammatory stage toward injury 
resolution, remains largely unknown.
In this study, we show that during muscle repair, the   
macrophage-intrinsic MKP-1–p38 balance critically regulates 
the timely transition of macrophages from a proinflamma-
tory to antiinflammatory state and ultimate progression into 
an exhaustion-like state characterized by cessation of cytokine 
expression. Dysregulation of the sequential macrophage transi-
tional states by loss of MKP-1 results in defective satellite cell 
functions and muscle tissue regeneration, whereas satellite cell–
intrinsic MKP-1 appears dispensable for the healing process. 
Finally,  we  uncover  a  novel  mechanism  connecting  MKP-1 
and phosphatidylinositol 3-kinase (PI3K)–AKT antiinflamma-
tory activities through p38-regulated microRNA-21 (miR-21) 
expression during tissue repair.
Results
Different cytokine activation and silencing 
profiles of macrophage subsets during 
muscle regeneration parallel modifications 
of the p38–MKP-1 inflammatory pathway
In response to injury, two subsets of macrophages are sequen-
tially present in regenerating skeletal muscle. In acute injury 
models, damaged tissue first recruits Ly-6C
high monocytes/ 
macrophages that exhibit a proinflammatory cytokine activation 
profile, whereas at later stages, macrophages within muscle switch 
their phenotype to become predominantly Ly-6C
low, showing 
an antiinflammatory profile (Arnold et al., 2007). To determine 
whether the p38–MKP-1 inflammatory pathway is involved in 
this  regenerative  response  to  tissue  injury,  we  characterized 
by cell sorting (FACS) the different macrophage populations 
present in muscle of wild-type (WT) mice (by cell number and 
activation profile) after injection of cardiotoxin (CTX) and ana-
lyzed their p38–MKP-1 activity over time. As shown in Fig. 1 A, 
proinflammatory  Ly-6C
high  macrophages  constituted  the  pre-
dominant population from day 1 to 3, decreasing thereafter. At 
later time points, Ly-6C
low macrophages were the most abun-
dant, but their number was progressively reduced, paralleling 
tissue healing (Fig. 1 A).
Muscle macrophages exhibited a peak of p38 and c-Jun 
(as a JNK pathway indicator) activation at 3 d of damage de-
creasing thereafter (Fig. 1 B), whereas maximal MKP-1 expres-
sion was observed at 6 d (Fig. 1 C). Interestingly, p38 (but not 
JNK) remained active in macrophages at late stages after injury 
(10 d), suggesting a role of the p38 pathway in the resolution 
phase of inflammation. In agreement with a published study 
(Arnold et al., 2007), we observed that macrophages switched 
from proinflammatory (3 d, expressing IL-1 and TNF) to anti-
inflammatory (6 d, expressing TGF and IL-10), but notably, 
we found that, at more advanced stages of regeneration (8 and 
10 d after injury), muscle macrophages ceased the expression of 
both pro- and antiinflammatory cytokines (Fig. 1, A and C), 
turning into a “silenced” or “exhausted” state (i.e., this term im-
plies an incapacity to produce either pro- or antiinflammatory 
cytokines). The modulated p38 activity and MKP-1 expression 
in muscle-infiltrating macrophages during repair (Fig. 1, B and C) 
suggested that the p38–MKP-1 balance may regulate macro-
phage transitions from pro- to antiinflammatory states and the 
acquisition of the cytokine-silencing phenotype.
Loss of MKP-1 results in delayed and 
incomplete tissue recovery after injury
To provide evidence for a direct regulatory role of p38–MKP-1 
in inflammation after tissue injury, we used WT and MKP-1– 
deficient (MKP-1
/) mice. MKP-1
/ mice have an exacerbated   
inflammatory response to infection, being hypersensitive to endo-
toxin treatment through unrestricted p38 activation in macro-
phages (Chi et al., 2006; Hammer et al., 2006; Wu et al., 2006; 
Zhao et al., 2006). We tested whether the immune response and 
tissue  recovery  processes  would  also  be  dysregulated  in  the 
absence of MKP-1 after acute injury. There was no genotypic 
difference in the number of circulating leukocytes in the pe-
ripheral blood (2.7 ± 0.9 × 10
3 counts/µl in WT mice vs. 3.0 ±   
1.3 × 10
3 counts/µl in MKP-1
/ mice), and the number of infil-
trating macrophages was similar in both mouse genotypes 1 d   
after injury (Fig. 1 D), suggesting that macrophage recruitment 
in injured tissue was not affected by MKP-1 loss. At subsequent 
stages after injury (3, 6, and 10 d) there was a significant increase 
in the number of macrophages in MKP-1
/ compared with WT 
muscle (Fig. 1 D and Fig. S1, A and B). MKP-1
/ macrophages 
expressed active p38, as shown by serial immunohistochemical 
analyses with antiphospho-p38 and F4/80 antibodies (Fig. 1 E 
and Fig. S1 C). This was in agreement with the p38 activity 
profile observed in WT and MKP-1
/ macrophages subjected   
to proinflammatory stimulation in vitro (Fig. S1 D), strongly 
supporting that absence of MKP-1 in macrophages leads to un-
restricted p38 activation and inflammation in damaged tissue. 
Tissue recovery and resolution of inflammation were impaired   
at 6 and 10 d after injury in MKP-1
/ mice compared with 
WT. Indeed, strongly expressing embryonic myosin heavy chain   
(eMHC)–positive  myofibers  were  still  present  in  MKP-1
/ 
muscle, indicating ongoing de novo satellite cell–associated 
myogenesis at late stages after injury (Fig. 1 F). Moreover, the 
size of centrally nucleated fibers at 6 and 10 d after injury was 
reduced in the absence of MKP-1 (Fig. 1 G and Fig. S1 E). This 
result was consistent with the persistent expression of satellite 
cell  activation  and  differentiation  markers  (MyoD  and  Myo-
genin) in MKP-1
/ muscle at 10 d after injury (Fig. S1 F), indi-
cating deficient and delayed myofiber formation in MKP-1
/ 
mice compared with WT. The inefficient muscle regeneration 
process in the absence of MKP-1 after CTX injection was repro-
duced with tissue laceration, an alternative experimental injury JCB • VOLUME 195 • NUMBER 2 • 2011   310
and fusion rates of cultured WT and MKP-1
/ satellite cells, 
correlating  with  a  similar  p38  activation  pattern  during  the   
differentiation  process  (Fig.  S2,  E–I).  Remarkably,  addition   
of conditioned media (CM) from in vitro–activated primary 
MKP-1
/ macrophages to cultured satellite cells increased 
their proliferation rate compared with CM from WT macro-
phages (Fig. S3 A). In contrast, CM from MKP-1
/ macro-
phages, but not WT CM, reduced the extent of satellite cell 
differentiation (Fig. S3 B) and fusion (not depicted). Interest-
ingly, these effects were reversed by specific neutralization of 
the cytokine TNF in MKP-1
/ CM (Fig. S3, A and B), sug-
gesting that the inhibitory actions of MKP-1
/ macrophage-
secreted factors on satellite cell functions may be exerted through 
proinflammatory cytokines.
The early pro- to antiinflammatory 
macrophage phenotypic transition is 
regulated by the MKP-1–p38 balance 
during tissue repair
We  investigated  whether  the  MKP-1–p38  pathway  would  be 
mechanistically implicated in the early transition of pro- to anti-
inflammatory macrophages. Unlike WT macrophages, FACS-
isolated MKP-1
/ muscle macrophages (Fig. S3, C and D) of both 
Ly-6C
high and Ly-6C
low populations expressed high levels of anti-
inflammatory cytokines in addition to proinflammatory cytokines   
3 d after injury (Fig. 3 A and Fig. S4 A). Because in WT macro-
phages, antiinflammatory cytokine expression was restricted to the 
Ly-6C
low population in 6-d damaged muscle after injury (Fig. 3 A,   
right), our results indicate that loss of MKP-1 anticipates the anti-
inflammatory gene program after tissue damage, resulting in a tem-
poral overlap of pro- and antiinflammatory cytokine expression. 
approach (Fig. S2 A; Menetrey et al., 1999). Because the initial 
number of satellite cells (identified by Pax7 [paired box protein 7]   
expression) and the cross-sectional area (CSA) of adult myo-
fibers under basal (nonregenerating) conditions were identical 
in both genotypes (Fig. S2, B and C), MKP-1 loss appears to 
specifically inhibit muscle regeneration in the adult, being dis-
pensable for muscle formation during development.
Inflammatory MKP-1, rather than satellite 
cell–intrinsic MKP-1, is necessary for 
correct muscle tissue repair
To clarify the relative contribution of inflammatory cell– versus 
satellite cell–intrinsic MKP-1 functions during muscle tissue 
repair, we undertook distinct experimental approaches. First, 
we evaluated whether transplantation of MKP-1–expressing bone 
marrow (BM) cells could restore muscle regeneration capacity 
in MKP-1
/ mice after injury. Transplantation of WT BM not 
only restored normal inflammation, but more importantly, it com-
pletely rescued the defective muscle regeneration in MKP-1
/ 
mice (MKP-1
/(WT BM)) when compared with WT(MKP-1
/ 
BM), as indicated by the decreased macrophage number and 
the increased CSA of regenerating fibers at 10 d after injury,   
respectively. This data demonstrates that BM/inflammatory 
cell  MKP-1 expression is critical for muscle repair (Fig. 2,   
A  and  B).  Second,  to  ascertain  the  intrinsic  contribution  of 
MKP-1 to satellite cell functions, we analyzed the satellite cell 
progeny of WT and MKP-1
/ single myofibers ex vivo. We 
found no difference in the number of myofiber-associated satel-
lite cells expressing Pax7 at basal stage or 48 h and Myogenin 
at 72 h in both genotypes (Fig. S2 D). Furthermore, no differ-
ences were observed in the proliferation, differentiation, migration, 
Figure  2.  A  dysregulated  inflammation   
underlies  the  defective  muscle  regeneration 
of MKP1
/ mice. (A) Effect of bone marrow 
(BM) transplantation. (left) Number of infiltrat-
ing macrophages after BM transplantation at 
10 d after injury. (right) CSA of regenerating 
myofibers in gastrocnemius muscles after BM   
transplantation. (B) Frequency curves of myo-
fiber  size  distribution  in  regenerating  gas-
trocnemius muscles after BM transplantation.   
BM  donors  are  enclosed  in  parentheses. 
Means ± SEM of at least three experiments. 
***, P < 0.001.311 MKP-1–p38 controls inflammation-mediated tissue repair • Perdiguero et al.
in response to an inflammatory stimulus (either lipopolysaccharide 
[LPS] or recombinant HMGB1), cultured MKP-1
/ macrophages 
simultaneously expressed high levels of pro- and antiinflamma-
tory cytokines, coinciding with p38 hyperactivation in compari-
son with WT macrophages (Fig. S4 B and not depicted; Chi et al., 
2006; Hammer et al., 2006; Wu et al., 2006; Zhao et al., 2006). 
Thus, during the early stages of tissue repair, MKP-1 controls 
both the overall magnitude of the inflammatory response as well as 
the timing of macrophage polarization via p38 down-regulation.
Interestingly, p38 inhibition in vivo by SB203580 treatment of 
MKP-1
/ damaged tissue restored both cell number and cyto-
kine expression pattern of MKP-1
/ Ly-6C
high and Ly-6C
low 
macrophages at 3 d after injury, resembling those of WT macro-
phages (Fig. 3, A and B). It is worth mentioning that the ex vivo 
analysis of FACS-sorted macrophages within injured muscle has 
allowed us to specifically study the effect of p38 inhibition on macro-
phage cytokine production, hence bypassing potential effects of 
SB203580 on other cell types. Consistent with the in vivo results, 
Figure 3.  MKP-1
/ macrophage population subsets display a mixed pro- and antiinflammatory phenotype at early stages of the muscle repair process 
and premature cytokine silencing at later stages caused by p38 hyperactivation. (A) Genes were analyzed by RT-PCR in isolated macrophage popula-
tions at 1, 3, and 6 d postinjury (P.I.). (bottom) A model of the temporal macrophage phenotypes in WT and MKP1
/ damaged muscles during repair.   
(B) F4/80-positive cells present in injured muscles of WT and MKP1
/ mice systemically treated with SB203580 (from 1 to 3 or 3 to 6 d) were analyzed for 
Ly-6C expression by flow cytometry. Total number of cells per milligram of injured muscle tissue was calculated. Means ± SEM of at least three experiments. 
***, P < 0.001; **, P < 0.01.JCB • VOLUME 195 • NUMBER 2 • 2011   312
muscle, Ly-6C
low macrophages expressed almost undetectable 
levels of antiinflammatory (or proinflammatory) cytokines. This 
indicates that, during the repair process, loss of MKP-1 in muscle 
macrophages leads to premature silencing of cytokine expres-
sion (both pro- and antiinflammatory; Fig. 3 A, right), though 
other macrophage markers remained expressed (Fig. S4 A). We 
postulated that the premature expression of antiinflammatory 
Cytokine gene silencing during the 
resolution of inflammation at late stages  
of tissue recovery is controlled by the 
MKP-1–p38 balance
Unexpectedly, we found that the mixed pro- and antiinflamma-
tory phenotype of MKP-1
/ macrophages present at 3 d after 
tissue injury was transient because in 6-d damaged MKP-1
/ 
Figure 4.  Forced premature expression of the antiinflammatory cytokine IL-10 impairs normal muscle repair. (A) Recombinant IL-10 or IGF-1 (used as a 
control) was injected twice during the early stages of regeneration after CTX injury (Inj.). 7-d injured gastrocnemius muscles obtained from vehicle-treated 
mice or mice treated with IL-10 at 7 d postinjury (P.I.) were stained with an anti-eMHC antibody, and the mean area of regenerating myofibers was cal-
culated. Bar, 50 µm. (B) WT satellite cells were cultured in GM for 24 h with 10 ng/ml IL-10, 30 ng/ml TNF, or a combination of both. (left) Cells were 
incubated for 1 h with BrdU, and positive cells were quantified. (right) Satellite cells were cultured in DM for 48 h with the same treatment, and Myogenin 
and MCK expression was analyzed. (C) Single myofibers, with their associated satellite cells, isolated from mouse muscles were cultured ex vivo in GM as 
in B for 72 h. Satellite cells were stained for Myogenin (Mgn; green) and TO-PRO-3 (red), and the number of positive cells in each fiber was counted. Bar, 
100 µm. NT, nontreated cells. Means ± SEM of at least three experiments. **, P < 0.01.313 MKP-1–p38 controls inflammation-mediated tissue repair • Perdiguero et al.
transition. SB203580 treatment of WT macrophages (initiated 
at the same time or after endotoxin stimulation) reduced both 
the early proinflammatory (IL-1 and TNF) and the late anti-
inflammatory (TGF and IL-10) waves of cytokine expression 
(Fig. 5 A). Similar results were obtained when HMGB1 was   
used as an initiating stimulus (unpublished results). In addition, 
the late IL-10 and TGF mRNA induction in these cells was 
blocked by actinomycin D and by cycloheximide (CHX; Fig. 5 B), 
suggesting the requirement of a newly synthesized protein   
intermediate for antiinflammatory cytokine expression. When 
the function of IL-1 was blocked with an IL-1 neutralizing 
antibody, the late LPS-dependent IL-10 and TGF induction in 
macrophages was significantly reduced (Fig. 5 C). Conversely, 
recombinant IL-1 was able to induce the expression of both 
antiinflammatory cytokines (in the absence of LPS; Fig. 5 C). 
Interestingly, this latter effect did not require de novo protein 
synthesis but was dependent on p38 activity, as indicated from 
combined treatments with recombinant IL-1/CHX and IL-1/
SB203580, respectively (unpublished data). This data strongly 
supports the direct action of IL-1 on antiinflammatory gene 
expression mediated by p38. Hence, in response to an initial 
insult, the early macrophage proinflammatory response (i.e., 
IL-1 and likely also TNF production) is required for the acti-
vation of the subsequent antiinflammatory response (i.e., IL-10 
and TGF production), which in turn may help to terminate the 
overall inflammatory reaction. Collectively, this indicates that 
the p38–MKP-1–controlled transition of macrophages from a 
pro- to an antiinflammatory phenotype appears critical, first, 
to counter the early proinflammatory cytokine environment in 
the damaged tissue, and, second, to directly stimulate satellite 
cell–mediated differentiation and fusion to newly forming myo-
fibers, thus ensuring timely and successful tissue regeneration.
AKT activity mediates the p38–MKP-1– 
controlled pro- to antiinflammatory 
macrophage transition at early tissue 
repair stages through an miR-21/PTEN-
dependent mechanism
To further understand mechanistically how p38–MKP-1 regu-
late these macrophage inflammatory transitions, we checked 
the AKT activation status of WT and MKP-1
/ macrophages 
in damaged muscle because an antiinflammatory role for AKT 
in response to LPS has been previously suggested (Guha and 
Mackman, 2002; Luyendyk et al., 2008). AKT activity was re-
duced in macrophages at early phases of tissue regeneration, 
coinciding with the mixed pro- and antiinflammatory profile, 
and in more advanced stages of the repair process, AKT activ-
ity remained higher in MKP1
/ macrophages (Fig. 6 A and 
Fig. S4 D). This higher activity correlated with loss of pro- and 
antiinflammatory cytokine gene expression in the absence of 
MKP-1 and suggested the likely requirement of AKT inhibi-
tion for pro- to antiinflammatory cytokine switching and sub-
sequent  cytokine  silencing  in  WT  macrophage  at  advanced 
stages of tissue repair.
First, to clarify whether AKT activity could control the 
timing of macrophage polarization, WT mice were treated with 
the PI3K–AKT inhibitor wortmannin 3 d after injury, and the 
cytokines in the absence of MKP-1 could underlie the prema-
ture silencing or exhaustion of the cytokine expression program 
in macrophages. Supporting this, addition of recombinant IL-10 
and/or TGF was able to advance the decline of cytokine   
expression in WT macrophages in response to a proinflamma-
tory stimulus (Fig. S4 C). The in vivo macrophage phenotype 
caused by MKP-1 loss was even more unexpected when consid-
ering the higher number of macrophages and the persistence   
of  tissue  damage  in  MKP-1
/  mice  (compared  with  WT 
mice) 6 d after injury (Fig. 3 B and Fig. S1 E). Importantly, 
macrophages in SB203580-treated MKP-1
/ tissue regained 
an antiinflammatory cytokine expression profile similar to WT 
macrophages, as indicated after FACS analysis (Fig. 3 A, right). 
Thus, as tissue repair advances, the p38–MKP-1 balance con-
trols, first, the pro- to antiinflammatory macrophage polariza-
tion and, later, the transition to an exhausted state with cessation 
of cytokine expression.
Interference with the ordered expression  
of pro- and antiinflammatory cytokines 
alters the course of tissue repair
To test whether the premature expression of antiinflammatory 
cytokines  in  MKP-1
/  muscle  macrophages  (overlapping 
with that of proinflammatory cytokines) might contribute in 
part to the inefficient repair of MKP-1
/ muscles, we tried 
to recapitulate this mixed inflammatory status in injured WT 
muscle  and  analyzed  the  consequences  on  new  myofiber 
growth. Local delivery of IL-10 early after WT muscle injury 
(2 and 4 d after CTX injection, when proinflammatory cyto-
kine expression is predominant) reduced the CSA of newly 
forming fibers measured at 7 d after injury compared with 
saline-treated contralateral damaged muscle (Fig. 4 A). As 
a control, no reduction of myofiber CSA was observed after 
IGF-1  (insulin-like  growth  factor  1)  administration.  These   
in vivo results were complemented with two ex vivo satellite 
cell–based models. Treatment with IL-10 was found to re-
verse the proproliferative effect of TNF on cultured satellite 
cells, as shown by BrdU incorporation (Fig. 4 B, left) and 
cell counting (after 5 d in culture, TNF increased the number 
of satellite cells by 25 ± 3.5% over WT numbers), whereas   
TNF/IL-10  co-stimulation  did  not  have  a  proproliferative   
effect. Conversely, the differentiation-promoting effect of IL-10   
on satellite cells, as shown by enhanced Myogenin and muscle 
creatine kinase (MCK) expression, was abolished by cotreat-
ment with TNF (Fig. 4 B, right). Finally, in isolated single 
myofibers from adult mouse muscle, the simultaneous addition 
of TNF and IL-10 for 72 h reduced the number of Myogenin
+ 
satellite cells per fiber (Fig. 4 C). Thus, timely, sequential 
expression of pro- and antiinflammatory cytokines produced 
by specific macrophage subsets appears critical to allow, first, 
satellite cell proliferation and, later, their differentiation and 
fusion into myofibers. Consistent with this, premature initia-
tion of the antiinflammatory cytokine program in injured WT 
muscle with IL-10 (mimicking MKP-1 loss) led to inefficient 
tissue healing.
Next, we aimed to investigate further the direct require-
ment of p38 to regulate this pro- to antiinflammatory macrophage JCB • VOLUME 195 • NUMBER 2 • 2011   314
an increased expression of miR-21 (Fig. 6 D). Notably, this 
was reversed by SB203580 delivery in vivo (Fig. 3 A), sug-
gesting that dysregulated miR-21 expression by hyperacti-
vated p38 leads to unrestrained AKT activity in the absence 
of MKP-1, which might underlie the enhanced presence of 
MKP-1
/  macrophages  at  advanced  tissue  repair  stages. 
Confirming this hypothesis, forced overexpression of miR-21 
(with a mimic miR-21), but not scrambled oligonucleotide 
miR (oligo-miR), in WT muscle macrophages (Fig. 6 E and 
Fig. S5 B) resulted in an increased number of antiinflam-
matory macrophages at a later injury stage. Furthermore, inhi-
bition of miR-21 with a specific antagonist miR (ant–miR-21) 
in endotoxin-treated macrophages attenuated the decline in 
cytokine expression over time while decreasing AKT activa-
tion (Fig. 6 F and Fig. S5, C and D). Conversely, miR-21 
overexpression with the mimic miR-21 reduced expression 
of both pro- and antiinflammatory cytokines (Fig. 6 G), sup-
porting the concept that miR-21 is an effector of p38 in mod-
ulating  macrophage  transition  tissue  persistence  via AKT 
activation. To directly prove that p38 regulates miR-21 expres-
sion, macrophages were infected with a retrovirus expressing   
macrophage number and activation status was analyzed 3 d later. 
Wortmannin delivery extended the expression of proinflamma-
tory cytokines till 6 d after injury while concomitantly enhancing 
antiinflammatory cytokine expression (Fig. 6 B and Fig. S5 A). 
Thus, transient PI3K–AKT inhibition in WT macrophages at 
early/mid stages of repair phenocopied the mixed cytokine acti-
vation status of MKP-1
/ macrophages observed shortly after 
injury. Consistent with this, we found that in cultured MKP-1
/ 
macrophages, the increased and mixed cytokine expression pat-
tern in response to a proinflammatory stimulus coincided with 
enhanced AKT activation (Fig. 6 C and Fig. S4 B).
We next wanted to elucidate how the MKP-1–p38 bal-
ance controls AKT activation in macrophages. Recently, the 
tumor-associated miR-21 was found to be up-regulated in 
RAW264.7 cells stimulated with LPS (Sheedy et al., 2010). 
Because the AKT-inactivating phosphatase PTEN is a bona 
fide target of miR-21 (Meng et al., 2007), we tested whether 
the miR-21/PTEN axis could be operating in macrophages. 
Consistent with enhanced AKT activation, PTEN levels were 
lower in FACS-isolated MKP-1
/ macrophages compared 
with WT at 6 d after injury (Fig. 3 A, right), coinciding with 
Figure 5.  Early p38-induced IL-1 stimulates the later expression of the antiinflammatory cytokines IL-10 and TGF in cultured macrophages. (A) Primary 
macrophages were cultured in vitro and stimulated with LPS. At the time of stimulation, or after 1.5 h, cells were treated or not treated with SB203580 (SB) 
for the indicated times. Comparative qPCR analysis. NT, nontreated cells. (B) Primary macrophages were treated with LPS ± SB203580, cycloheximide 
(CHX), or actinomycin D (Act D). (C) As in B, cells were treated with an IL-1 neutralizing antibody, control IgG antibody, or recombinant IL-1 for 24 h (in 
this case, in the absence of LPS). Means ± SEM of at least three experiments. *** or 
#, P < 0.001; **, P < 0.01; *, P < 0.05.315 MKP-1–p38 controls inflammation-mediated tissue repair • Perdiguero et al.
Cessation of cytokine expression  
required for resolution of inflammation  
at late stages of tissue recovery depends 
on AKT activity
As shown in Fig. 1, p38 remained active in macrophages at late 
stages after injury when tissue is almost fully recovered (10 d), 
coinciding with a decline in MKP-1 expression, sustained activ-
ity of AKT, and cessation of the expression of both pro- and anti-
inflammatory cytokine expression. Furthermore, compared with 
WT mice, AKT activity was also higher in MKP1
/ macro-
phages at 6 d (and also at 10 d after injury; Fig. 6 A and Fig. S4 D), 
correlating with its unscheduled cytokine silencing (Fig. 1 C), 
a constitutively active form of MKK6 (MKK6E), the p38- 
activating kinase (Cuenda et al., 1996), As shown in Fig. 6 H, 
MKK6E-activated p38 could directly induce miR-21 gene 
expression in macrophages in the absence of stimuli, and this 
induction was blunted by SB203580 treatment, likely through 
a previously described AP-1 binding site within the miR-21 
gene promoter (Qi et al., 2009; Roy et al., 2009; Ribas and 
Lupold, 2010). In support of this possibility, overexpression 
of a form of ATF2 not phosphorylatable by p38, but not WT 
ATF2 (a well-known substrate of p38 that can bind to AP-1 
sites), also abrogated the MKK6E/p38-mediated induction 
of miR-21 (Fig. S5 E).
Figure 6.  Increased AKT activity in MKP-1
/ 
macrophages  is  controlled  by  p38-induced 
miR-21  expression.  (A)  Phospho-AKT  (P-AKT)– 
positive  macrophages  were  counted  from 
immunostained  serial  cryosections  of  gas-
trocnemius  muscles  obtained  from  WT  and   
MKP-1
/ mice postinjury (P.I.; see pictures in   
Fig.  S5  D).  (B)  Gene  expression  analysis   
by  RT-PCR  in  FACS-isolated  macrophage 
populations  at  6  d  after  injury  from  mice 
treated  with  wortmannin  or  vehicle  for  the 
preceding  3  d.  (C)  WT  and  MKP-1
/  
BM macrophages were stimulated with LPS at 
the indicated times. Western blotting analy-
sis using phospho-AKT and AKT antibodies.   
(D) Expression of miR-21 was analyzed by qPCR 
in isolated macrophage populations at 3 and 
6 d after injury from WT and MP-1
/ mice 
or  WT  mice  treated  with  SB203580  (SB).   
(E) Total number of macrophages per milligram 
of muscle at 6 d after injury. Muscles were in-
jected with scrambled or mimic miR-21 oligo-
nucleotides  at  3  d  after  injury.  (F)  Primary 
macrophages  were  transfected  with  scram-
bled  or  ant–miR-21  oligonucleotides  and 
stimulated  with  LPS  for  the  indicated  times; 
IL-1 or IL-10 expression analysis. (G) As in F, 
primary macrophages were transfected with 
scrambled (Scr) or miR-21 mimic oligonucleo-
tides.  (H)  Primary  macrophages  infected 
with  a  retrovirus  expressing  MKK6E  or  an 
empty retrovirus (C, control), in the absence 
or presence of SB203580, were analyzed for 
MKK6, phospho-p38 (P-p38), phospho-ATF2 
(P-ATF2),  and  p38  expression  by  Western 
blotting (left) or for miR-21 mRNA expression 
by qPCR analysis (right). Means ± SEM of at 
least three experiments. 
# or ***, P < 0.001; 
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Figure 7.  Transient PI3K–AKT inhibition in WT macrophages maintains cytokine expression and prevents cytokine silencing at late stages of the tissue 
repair process. (A) Gene analysis by RT-PCR in FACS-isolated macrophage populations at 8 and 10 d after injury from mice treated with wortmannin 
(Wort) or vehicle for the preceding 2 d. (B) Anti–IL-10 neutralizing antibody was injected twice during the later stages of muscle regeneration after CTX 317 MKP-1–p38 controls inflammation-mediated tissue repair • Perdiguero et al.
delivery to WT tissue, besides preventing temporal macrophage 
transitions during the course of repair (as shown in Fig. 7), also 
resulted in a reduced number of macrophages at late stages after 
injury (6 and 8 d; Fig. S5 F). Together, these results strongly 
support the idea that MKP-1 loss, through unrestrained p38   
activation, promotes persistence of macrophages in a cytokine- 
silencing state in injured muscle by increasing AKT activation. 
Thus, defective regeneration of MKP-1
/ mouse muscle might be 
ascribed, at least in part, to the excessive presence of nonproduc-
tive macrophages in damaged tissue, via sustained/enhanced 
AKT activity.
Discussion
Unsuccessful repair after tissue damage leads to the derange-
ment of normal structure and loss of function. Here, we demon-
strate that dysregulated macrophage transitions, with precocious 
pro- to antiinflammatory polarization followed by immediate 
cessation of cytokine expression, impair resolution of tissue 
damage and efficient repair. From a mechanistic point of view, 
our study provides evidence for a novel macrophage-specific 
role for MKP-1 in regulating the evolution as well as the resolu-
tion of inflammation during muscle tissue repair by controlling 
p38-mediated  AKT  activation.  Genetic  and  pharmacological 
interference with these signaling pathways also dysregulated 
inflammation-dependent  tissue  healing.  We  found  that  un-
restricted  p38  activity  induced  the  expression  of  miR-21  in 
MKP-1
/ macrophages, leading to down-regulation of its sub-
strate PTEN, thus inducing AKT activity. This dysregulated in-
flammatory response underlies the persistence of myofiber damage 
and impaired growth of regenerating myofibers in mice lacking 
MKP-1. Importantly, defective muscle regeneration in mice de-
ficient in MKP-1 could be completely restored by MKP-1
+/+ 
BM transplantation, strongly suggesting dispensability of this 
phosphatase for satellite cell–dependent myofiber repair. Our 
conclusions were confirmed by using in vitro satellite cell   
cultures and single myofiber explants. Satellite cell–intrinsic 
MKP-1 loss neither affected activation of p38 (a critical regula-
tory pathway in satellite cell behavior) or myogenesis in any of 
the models, whereas dysregulated cytokine production in mac-
rophages lacking MKP-1
/ altered satellite cell functions in a 
paracrine manner. Interestingly, previous studies had anti-
cipated a relevant function for MKP-1 in myogenesis (Bennett 
and Tonks, 1997; Wu et al., 2006; Roth et al., 2009; Shi et al., 
2010). The distinct findings concerning myogenesis could be 
explained by the different experimental models used, support-
ing the need for a future evaluation of MKP-1 function using 
muscle-specific deletion approaches.
A fundamental unanswered question important for under-
standing  the  pathogenesis  of  inflammation-associated  tissue 
thus suggesting that AKT, in addition to regulating the earlier 
pro- to antiinflammatory cytokine switching, might also be re-
quired  for  the  final  cytokine  silencing  in  WT  macrophages   
at advanced stages of tissue repair. To test this possibility, WT 
mice were transiently treated with wortmannin at 6 or 8 d after 
injury, and the macrophage number and activation status was 
analyzed 2 d later. Although macrophages in vehicle-treated 
WT  muscles  presented  a  silenced  cytokine  profile  (i.e.,  no   
expression of pro- or antiinflammatory cytokines), the transient 
wortmannin  treatment  prevented  full  cytokine  silencing,  as   
indicated by residual expression of both pro- and antiinflam-
matory cytokines (Fig. 7 A). Because transient SB2013580 
treatment prevented premature cytokine silencing of MKP-1
/ 
macrophages at 6 d after injury (Fig. 3 A), these results taken 
together strongly support a role for MKP-1 (through p38 neutral-
ization and subsequent AKT down-regulation) in controlling 
sequential  cytokine  activation-silencing  transitions  in macro-
phages during tissue repair by restraining AKT activation.
Prompted  by  these  results,  we  hypothesized  that  anti-
inflammatory cytokine neutralization at advanced tissue repair 
stages in WT muscles will provide an environment similar to 
that of MKP-1
/ muscles, which could affect the final tissue 
repair course. Confirming this possibility, delivery of an IL-10 
neutralizing  antibody,  at  intermediate–advanced  stages  after   
injury (4 and 7 d after CTX injection), reduced the size of   
regenerating fibers analyzed 10 d after injury compared with 
IgG-treated contralateral damaged muscle (Fig. 7 B), indicating 
that premature neutralization of antiinflammatory cytokines has 
deleterious consequences on the active growth of newly formed 
myofibers at advanced stages of tissue healing.
Finally, FACS analysis and immunohistochemistry showed 
a higher number of MKP-1
/ macrophages in injured muscle 
at any time point of the repair process, which could be reduced 
by SB203580 treatment (Fig. 3 B). Based on the major recog-
nized  role  of  the  PI3K–AKT  pathway  in  cell  proliferation/ 
survival, we reasoned that the altered AKT activation pattern in 
MKP-1
/  macrophages  might  also  change  their  growth/ 
survival properties, thereby affecting macrophage persistence in 
injured muscle. To demonstrate this, we performed F4/80 and 
TUNEL double immunostaining (Fig. 7 C) and found that dam-
aged MKP-1
/ muscles indeed had a reduced number of apop-
totic macrophages compared with WT muscle, correlating with 
an increased presence of Ki-67–positive cells (Fig. 7 D). In 
agreement with these data, FACS-isolated MKP-1
/ macro-
phages were found to express lower levels of the cell cycle   
inhibitors p21 and p27 than WT macrophages (Fig. 7 E), sug-
gesting  that  enhanced  survival  and  proliferation  rates  could   
account for the increased macrophage presence in MKP-1
/ 
damaged muscle, and this could be rescued by SB203580 treat-
ment (Fig. 7 E). Consistent with this, we found that wortmannin 
injury (Inj.), and muscles were isolated at day 8 and 10 postinjury (P.I.) and processed as in Fig. 4 A. IgG was used as a control. An outline of the experi-
ment is depicted. (C, top) Apoptotic F4/80-expressing macrophages were assessed by TUNEL staining. (bottom) CTX-injured gastrocnemius muscle from 
WT and MKP-1
/: F480 (red), TUNEL (green), and DAPI (blue). Regenerating fibers are indicated by dotted lines. Apoptotic nuclei are indicated by 
arrows. (D) Cell proliferation was assessed by Ki-67 staining as in C: Ki-67 (red) and DAPI (blue). (E) Expression of p21, p27, and -actin (as a loading 
control) was analyzed by RT-PCR in FACS-isolated macrophage populations at 6 d after injury as in Fig. 3 A. Means ± SEM of at least three experiments.   
**, P < 0.01. Bars, 50 µm.
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dysfunction is the nature of the molecular switch that differenti-
ates reparative inflammatory cell functions from pathological 
inflammatory  responses  to  tissue  damage.  In  addition  to  the   
initial  pro-  to  antiinflammatory  switch  previously  described   
(Arnold et al., 2007), our study identifies a final transit of macro-
phages  from  their  antiinflammatory  activation  state  to  an   
exhaustion-like state during the inflammation resolution phase, 
characterized by cessation of both pro- and antiinflammatory   
cytokine expression. We found that the early pro- to the anti-
inflammatory macrophage transition, as well as the final pro-
gression into a cytokine-silencing state, occurred prematurely in 
the absence of MKP-1 via unrestricted p38 activation. Thus, we 
have revealed a novel function of the p38–MKP-1 balance in the 
resolution of inflammation and tissue repair. Indeed, end-stage 
macrophages that remain in almost fully recovered muscle retain 
a certain p38 activation status, whereas their cytokine expression 
program was silenced. Thus, our data reveal the first molecular 
determinants of the ordered macrophage inflammatory switches 
during muscle tissue repair. Consistent with this, the premature 
delivery of the antiinflammatory cytokine IL-10 to WT muscle 
shortly after injury during the early proinflammatory phase or, 
conversely,  its  premature  neutralization  (mimicking  cytokine   
silencing at advanced repair stages) had a deleterious impact on 
tissue recovery. Based on these results, it is tempting to propose 
that altered inflammatory cell phenotypes could underlie pathol-
ogies associated with deficient tissue healing.
Our study demonstrates a functional MKP-1–controlled 
p38–miR-21–AKT pathway operating at advanced stages of the 
repair process. That is, this axis regulates macrophage fate over 
time, such as the acquisition of macrophage antiinflammatory 
status, apoptosis, and final silencing of the cytokine gene pro-
gram contributing to the resolution of inflammation. We propose 
that, as damaged tissue is cleared, macrophage-produced anti-
inflammatory cytokines shut down the early acute proinflammatory 
wave, and eventually, when tissue has fully recovered, macro-
phages undergo apoptosis and/or return to a resting state.   
Indeed, as growth of regenerating myofibers increased in WT 
mice, muscle macrophage apoptosis was more pronounced, and 
unexpectedly, the surviving macrophages ceased the expression 
of both pro- and antiinflammatory cytokines. In contrast, blunted 
myofiber growth in the absence of MKP-1 correlated with the 
increased  presence  of  (prematurely  silenced)  muscle  macro-
phages, which could be ascribed to attenuated cell apoptosis 
and enhanced proliferation caused by dysregulation of the 
PI3K–AKT pathway in these cells. Consistent with this, phar-
macological inhibition of AKT was able to perturb normal mac-
rophage cell behavior in injured muscle over time and could 
also delay cytokine silencing during the resolution of inflamma-
tion.  Thus,  by  sequentially  controlling  macrophage-intrinsic 
p38-dependent AKT activation, MKP-1 emerges as an impor-
tant regulator of inflammation-mediated tissue repair beyond 
sepsis prevention.
Interestingly, it has been described that upon endoplas-
mic reticulum stress or proapoptotic signals, p38 promotes sur-
vival of skin macrophages through direct activation of AKT by 
MK2 (Seimon et al., 2009). Moreover, the PI3K–AKT pathway 
negatively regulates MAPKs and proinflammatory gene expres-
sion in BM-stimulated macrophages in vitro (Luyendyk et al., 
2008). We now propose that p38, by inducing IL-1 at the early 
proinflammatory  macrophage  stage  after  injury,  stimulates 
TGF expression in antiinflammatory macrophages. Indeed, p38 
inhibition at early stages after injury reduces IL-1 expression 
in proinflammatory cells and affects TGF expression in anti-
inflammatory muscle macrophages (unpublished data). Macro-
phage-produced TGF, in turn, will further promote miR-21 
maturation and subsequent PTEN down-regulation and AKT 
activation, thereby affecting cytokine gene silencing and macro-
phage cell number as tissue repair advances. Additionally, we 
demonstrated that p38 activation could directly induce miR-21 
gene transcription in macrophages (Fig. 6 H), likely through 
AP-1 binding sites on the miR-21 promoter (Qi et al., 2009; 
Roy et al., 2009; Ribas and Lupold, 2010), reinforcing the idea 
that p38 might promote miR-21 expression in macrophages by 
direct and indirect mechanisms. Together, our results allow us 
to draw a model in which p38–MKP-1 and AKT–PTEN path-
ways act sequentially and interact with each other through cross- 
regulatory feedback mechanisms at different levels (Fig. 8).
The expression of miR-21 was found dysregulated (in-
creased) in MKP-1
/ macrophages at advanced stages of   
muscle damage. The function of miR-21 has been classically 
associated with cancer based on its high expression in most   
human tumors (Selcuklu et al., 2009), but no role for miR-21 has 
yet been described either in inflammation or in muscle repair. It 
is now becoming evident that miR-21 may represent a common 
feature of pathological cell growth and stress. This is illustrated 
by its recently reported roles in cardiac and lung remodeling, by 
virtue of inhibiting different targets, including Smad7, Sprouty 1, 
or PTEN (Thum et al., 2008; Hatley et al., 2010; Liu et al., 
2010),  which  in  turn,  can  control  cell  stress  responses.  We 
found that during the course of tissue healing, MKP-1 ablation 
led to p38-dependent up-regulation of miR-21 in macrophages, 
Figure 8.  Proposed model for the role of the p38–MKP-1 balance in con-
trolling ordered macrophage transitions during tissue repair.319 MKP-1–p38 controls inflammation-mediated tissue repair • Perdiguero et al.
mouse within 24 h after irradiation. The mice were placed in sterile cages 
and fed with sterile chow until the reconstitution of BM was completed   
8 wk after the transplantation. No changes in general health status were 
noted in the recipient mice. Regeneration of skeletal muscle was induced 
by intramuscular injection of CTX as described in the Induction of muscle 
regeneration subheading.
Isolation and culture of primary macrophages
To generate BM-derived macrophages (BMDMs), BM cells were flushed 
from the femurs of mice. Cells were differentiated in DME supplemented 
with 20% heat-inactivated FCS and 30% L929 supernatants containing the 
macrophage-stimulating factor for 5–7 d. Cells were harvested and plated 
at a density of 2–4 × 10
5/ml in RPMI supplemented with 5% FBS. At 24–
48 h after replating, cells were stimulated for various times with 10 ng/ml 
LPS (Sigma-Aldrich). CM from WT or MKP-1
/ BMDMs was obtained by 
stimulating cell cultures for 2 h with LPS, changing to fresh medium, and 
leaving it 4 h before collection. Knockdown (ant–miR-21) and overexpres-
sion (mimic) of miR-21 and scrambled control oligonucleotides (Thermo 
Fisher  Scientific)  or  overexpression  of  a  WT  and  nonphosphorylatable 
ATF2 plasmids (WT ATF2 and T69A/T71A ATF2; Akimoto et al., 2005) 
was performed via electroporation using the mouse macrophage Nucleo-
fector kit (Lonza). When indicated, cells were stimulated with 100 ng/ml 
LPS (Sigma-Aldrich), 2 µg/ml actinomycin D (Sigma-Aldrich), 10 µg/ml 
CHX (Sigma-Aldrich), 30 ng/ml recombinant IL-1 (R&D Systems), and   
30 ng/ml of a blocking antibody anti–IL-1 (R&D Systems). SB203580 
was used at 5 µM.
Retroviral infection was performed with pCLNCX-MKK6E or empty 
vector packaged in 293T cells with an ecotropic envelope. In brief, the vi-
ruses were generated by cotransfection of the plasmids form of 25 µg retro-
viral vectors and 5 µg packaging construct (pCLEco) in the 293T cell line 
by calcium phosphate precipitation. The following day, precipitates were 
removed, and fresh medium was added. This medium containing the viral 
particles was recovered 48 h later and centrifuged at 3,000 g for 10 min. 
Cultures were infected by adding to each plate 6 ml medium containing 
the viral particles, 6 ml medium, 10 µl Hepes (1 M), pH 7.3, and 4 µg 
polybrene (Sigma-Aldrich) per ml. The medium was removed 24 h later, 
and the cells were then cultured as indicated
Isolation of muscle macrophages by FACS
Hind-limb muscles were collected and weighed. Injured muscle weight re-
duced steadily with a peak of reduction (40–50%) at 6 d after injury. 
Muscles were dissociated in DME containing collagenase B 0.2% (Roche) 
and 0.2% trypsin-EDTA at 37°C for 45 min twice, filtered, and counted. 
Cells were separated using a Percoll gradient and stained with FITC- 
conjugated  anti-CD45,  allophycocyanin-Cy7–conjugated  F4/80  and 
phycoerythrin-conjugated Ly-6C antibodies (BD). Cells were sorted using 
a cell sorter (FACS Aria II; BD). Populations presenting >90% purity were 
used. Cells consisted in a homogeneous monocyte/macrophage popula-
tion, as indicated by their mononuclearity, read as low orthogonal (side) 
scatter in the flow cytometer. Total number of cells was normalized by 
milligram of wet tissue.
Isolation and culture of muscle satellite cells
Hind-limb muscles from mice were excised, separated from adipose and 
connective tissue, minced into a coarse slurry, and then digested for 1 h 
with 0.1% pronase (Sigma-Aldrich) in DME at 37°C with mild agitation. 
The digest was then mechanically dissociated by repeated trituration fol-
lowed by filtration through a 100-µm vacuum filter (Millipore). The filtered 
digest was centrifuged through an isotonic Percoll gradient (60% over-
laid with 20%). Mononucleated cells in the Percoll interface were col-
lected and resuspended in Ham’s F10 medium supplemented with 20% 
FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, 0.001% Fungizone, 
and 5 ng/ml basic FGF (growth medium [GM]). Primary satellite cell cul-
tures were maintained on a routine basis on collagen-coated dishes in 
GM. The medium was changed daily, and cultures were passaged 1:3 as 
they reached 60–70% confluence. Experiments were performed by plat-
ing cells on Matrigel Basement Membrane Matrix–coated dishes (BD). To 
maintain the primary characteristics of the cells, all experiments were 
performed using cultures that had undergone between four and seven 
passages. All experiments were performed with independent cell isolates 
from at least three different animals for each genotype. To induce muscle 
differentiation and fusion, GM was replaced by differentiation medium 
(DM; DME supplemented with 2% horse serum, 2 mM l-glutamine, 100 U/ml 
penicillin, 100 µg/ml streptomycin, and 0.001% Fungizone) at satellite 
cell subconfluence.
which  temporally  correlated  with  reduced  PTEN  expression 
levels and increased AKT levels. Therefore, an inflammatory regu-
latory cascade can be proposed by which, as tissue repair pro-
gresses, macrophage p38 activity is controlled by reexpression of 
MKP-1, resulting in reduced miR-21–driven macrophage sur-
vival via PTEN-dependent inhibition of AKT (Fig. 8, model).
PTEN  mutations  are  often  found  in  human  cancers   
(Keniry and Parsons, 2008), and loss of p38 in vivo enhances 
tumorigenesis in several mouse cancer models (Ventura et al., 
2007; Wagner and Nebreda, 2009). Conversely, miR-21 is 
emerging as a potent onco-miR (Medina et al., 2010). Thus, in 
addition  to  the  well-established  cancer  inflammation  link 
(Grivennikov and Karin, 2010), this study may extend the com-
monalities between cancer progression and chronic inflamma-
tion-associated degenerative diseases. As interference with the 
individual components of this signaling pathway can be pres-
ently accomplished by using small inhibitory molecules (now 
entering human clinical trials), our study suggests novel, easy to 
test approaches to attenuate inflammatory degenerative diseases 
and to enhance stem cell–driven tissue repair, especially in long-
term severe inflammatory myopathies.
Materials and methods
Mice
Mice carrying a disruption within exon 2 of MKP-1 (MKP-1
/) were de-
rived by implantation of heterozygotic (MKP-1
+/) C57BL6 embryos into 
surrogate mothers (a gift by R. Bravo, Bristol-Myers Squibb, Princeton, NJ; 
Dorfman et al., 1996). All experiments were performed with mice gener-
ated from intercrossed heterozygotes. All animal experiments were approved 
by the Catalan Government Animal Care. For drug treatments, mice were 
injected intraperitoneally with vehicle or SB203580 (EMD) at a concentra-
tion of 5 mg/kg body weight every second day (Bulavin et al., 2004) or 
wortmannin (Sigma-Aldrich) at a concentration of 1 mg/kg body weight at 
the indicated times. SB203580 and wortmannin selected concentrations were 
shown to inhibit p38 and AKT activation, respectively (unpublished data).
Induction of muscle regeneration
Animals were anesthetized with 80/10 mg/kg ketamine/xylazine (intra-
peritoneally). Regeneration of skeletal muscle was induced by intramuscu-
lar injection of 50 µl of 10
5 M CTX (Latoxan) in the gastrocnemius muscle 
group of the mice as previously described (Suelves et al., 2007). The ex-
periments were performed in the right hind-limb muscles of mice. Contralat-
eral uninjured muscles were used as a reference. For cytokines, 50 ng 
IL-10 (Peprotech) was injected in a volume of 50 µl in the injured muscle at 
the indicated times. For neutralizing antibodies, 25 µg anti–IL-10 (R&D 
Systems) was injected in a volume of 25 µl in the injured muscle at the indi-
cated  times.  For  miR-21  mimic  oligonucleotides,  5  µg  miR-21  mimics 
(Thermo Fisher Scientific; sequences are based on Sanger miRBase) were 
injected in the injured muscle at 3 d after injury, and muscles were ana-
lyzed at day 6. Morphological and biochemical examinations were per-
formed on muscles collected at the indicated days after injury.
Muscle laceration model
Laceration of the tibialis muscle was performed as previously described 
(Menetrey et al., 1999) with minor modifications. In brief, tibialis muscles 
were cut at 60% of the length from their distal insertion, through 75% of their 
width and 50% of their thickness. After controlling the bleeding with cauteriza-
tion or simple compression, muscles were sutured. The mice were sacri-
ficed at 21 d after injury, and the muscles were flash frozen in 2-methylbutane 
precooled in liquid nitrogen and stored at 80°C until histological analysis.
BM transplantation
BM was performed as previously described (Suelves et al., 2007). In 
brief, BM cells were obtained by flushing the femurs and tibiae of donor 
mice with RPMI 1640 medium (Invitrogen) and were transplanted into re-
cipient mice after lethal irradiation (9 Gy). The reconstituting cells (5 × 
10
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RNA isolation, RT-PCR, and quantitative real-time PCR (qPCR)
Total RNA was isolated from macrophages or primary myoblasts using   
TriPure reagent (Roche) or miRNeasy Mini Kit (QIAGEN) and analyzed   
by RT-PCR or qPCR. RT-PCR primers used in this study were as follows: TNF, 
5-TTCCAGATTCTTCCCTGAGGT-3 and 5-TAAGCAAAAGAGGAGGC-
AACA-3; IL-1, 5-TGACGTTCCCATTAGACAACTG-3 and 5-CCGTCT-
TTCATTACACAGGACA-3; IL-10, 5-ACCAGCTGGACAACATACTGC-3 
and  5-TCACTCTTCACCTGCTCCACT-3;  TGF,  5-GAGACGGAATA-
CAGGGCTTTC-3 and 5-TCTCTGTGGAGCTGAAGCAAT-3; PTEN, 5-CATCT-
CTCTCCTCCTTTTTCTTCA-3 and 5-CAAACATCATCTTGTGAAACAGC-3; 
MKP-1,  5-TGGAGATCCTGTCCTTCCTG-3  and  5-AAGCTGAAGTTC-
GGGGAGAT-3; p21, 5-GTCCAATCCTGGTGATGTCC-3 and 5-CAGG-
GTTTTCTCTTGCAGAAG-3; p27, 5-CAAACGTGAGAGTGTCTAACG-3 
and 5-CGTCTGGCGTCGAAGGC-3; IL4R, 5-TGTAGCCCGGCCCC-
AAATCC-3 and 5-GGCGGCACCCTGCTTCACTG-3; Arg1, 5-GAAG-
AATGGAAGAGTCAGTGTGGTG-3 and 5-GAGGAGAAGGCGTTTGCT-
TAGC-3; HMGB1, 5-CGCGGAGGAAAATCAACTAA-3 and 5-GCAGA-
CATGGTCTTCCACCT-3; CD14, 5-CAGGTCCGCGTCTTCCCTGC-3 and 
5-AGCACGCTGAGCTTGGCTGG-3; CD16, 5-TCTGTGCGGAGGGG-
TCTTCA-3 and 5-AGGGTAGCTGCGTGCGCATT-3; and -actin, 5-CACC-
TTCTACAATGAGCT-3 and 5-GAAGGTAGTCTGTCAGGTCCC-3.
For qPCR experiments, DNase digestion of 10 µg RNA was per-
formed using 2 U DNase (TURBO DNA-free; Invitrogen). cDNA was syn-
thesized from 2 µg total RNA using the First-Strand cDNA Synthesis kit (GE 
Healthcare). For qPCR, reactions were performed on a LightCycler 480 
System using a LightCycler 480 SYBR Green I Master (Roche) and specific 
primers. Thermocycling conditions were as follows: initial step of 10 min at 
95°C and then 50 cycles of 15-s denaturation at 94°C, 10-s annealing at 
60°C, and 15-s extension at 72°C. Reactions were run in triplicate, and 
automatically  detected  threshold  cycle  values  were  compared  between 
samples. Transcripts of the ribosomal protein L7 gene were used as an en-
dogenous control, with each unknown sample normalized to L7 content. 
qPCRs primers used in this study were as follows: MyoD, 5-GCCGCCT-
GAGCAAAGTGAATG-3  and  5-CAGCGGTCCAGTGCGTAGAAG-3; 
Myogenin, 5-GGTGTGTAAGAGGAAGTCTGTG-3 and 5-TAGGCG-
CTCAATGTACTGGAT-3;  MCK,  5-AGGCATGGCCCGAGAC-3  and   
5-AGATCACGCGAAGGTGGTC-3;  MHC-2×  5-CTCCAGGCTGCTTTA-
GAGGAA-3 and 5-CCTGCTCCTAATCTCAGCATCC-3; p21, 5-CCAG-
GCCAAGATGGTGTCTT-3 and 5-TGAGAAAGGATCAGCCATTGC-3; TNF,   
5-CGCTCTTCTGTCTACTGAACTT-3 and 5-GATGAGAGGGAGGCCATT-3;   
IL-1, 5-CCAAAATACCTGTGGCCTTGG-3and 5-GCTTGTGCTCTGCTT-
GTGAG-3;  IL-10,  5-GTGGAGCAGGTGAAGAGTGA-3  and  5-CGAG-
GTTTTCCAAGGAGTTG-3;  IL-6,  5-GAGGATACCACTCCCAACAGACC-3  
and 5-AAGTGCATCATCGTTGTTCATACA-3; TGF, 5-CTCCACCTGCAA-
GACCAT-3 and 5-CTTAGTTTGGACAGGATCTGG-3; and L7, 5-GAAG-
CTCATCTATGAGAAGGC-3 and 5-AAGACGAAGGAGCTGCAGAAC-3.
For detection of mature miRNA, the TaqMan MicroRNA assay kit 
(Applied Biosystems) was used according to the manufacturer’s instruc-
tions. A mean of three experiments each performed in triplicate with stan-
dard errors is presented.
Western blotting
Preparation of cell lysates and Western blotting were performed as previ-
ously described in Perdiguero et al. (2007). In brief, cell lysates were pre-
pared with immunoprecipitation buffer (50 mM Tris HCl, pH 7.5, 150 mM 
NaCl, 1% NP-40, 5 mM EGTA, 5 mM EDTA, 20 mM NaF, and 25 mM   
-glycerophosphate) supplemented with protease and phosphatase inhibi-
tors (Complete Mini [Roche]; phosphatase inhibitor cocktail [Sigma-Aldrich]). 
Cleared lysates containing 50 µg protein were separated by SDS-PAGE 
and transferred to nitrocellulose membranes. Antibodies used were p38 C-20, 
JNK-1 C-17, MKP-1 M-18 (Santa Cruz Biotechnology, Inc.), phospho-p38, 
phospho-ATF2,  phospho-AKT,  AKT  (Cell  Signaling  Technology),  and   
-tubulin (Sigma-Aldrich).
Statistical analysis
Prism software (GraphPad Software) was used for all statistical analyses.   
Results from corresponding time points of each group were averaged and used 
to calculate descriptive statistics. One-way analysis of variance and Tukey 
posthoc test or a Kruskall Wallis and Dunn’s posthoc test was used on multiple 
comparisons and all possible pairwise comparisons among groups at each 
time point. Data are means ± SEM. Significance was accepted at P < 0.05.
Online supplemental material
Fig. S1 shows F4/80
+ cell numbers and representative pictures, phospho-
p38/c-Jun immunohistochemistry, in vitro p38 activity data, and repre-
sentative pictures of H/E staining of injured muscles after CTX injection. 
Proliferation, migration, and fusion assays
For the proliferation assay, satellite cells were cultured for 12 h in GM, and 
to detect S-phase cells, cultures were pulsed with BrdU (Sigma-Aldrich) 1 h 
before fixation in 3.7% formaldehyde for 10 min and were immunostained 
using anti-BrdU antibody (Oxford Biotech) and a specific secondary   
biotinylated goat anti–rat antibody (Jackson ImmunoResearch Laborato-
ries, Inc.) followed by quantification (see Perdiguero et al., 2007). Satellite 
cell migration assays were performed using transwells. Cells were plated 
on top of a transwell with 8-µm pore membrane (BD), previously coated 
with Matrigel, and immersed in a well of a 24-well culture plate with migra-
tion medium (DME with 1% FBS and 0.5% BSA) for 6 h. After incubation, 
cells on the upper surface of the membrane were removed using cotton 
swabs, and the membranes were fixed in 3.7% formaldehyde for 10 min 
and stained with 2% crystal violet. Stained cells that had migrated and ad-
hered to the transwell membrane were quantified by counting under the 
microscope (CKX41; Olympus).
For fusion analysis, cells were immunostained with anti-eMHC anti-
body, and nuclei within the eMHC-positive myofibers were quantified (see 
Perdiguero  et  al.,  2007).  When  indicated,  CM  of  WT  or  MKP1
/  
BMDMs was added.
Histology and immunohistochemistry
Gastrocnemius and plantaris muscles from WT and MKP-1
/ mice were 
frozen in isopentane cooled with liquid nitrogen and stored at 80°C until 
analysis. 10-µm sections were collected from the midbelly of muscles and 
were stained with hematoxylin/eosin (H/E).
Immunohistochemistry on muscle cryosections was performed with 
the  following  antibodies:  anti-Pax7,  anti-Myogenin  (F5D),  anti-eMHC 
(F1.652;  Developmental  Studies  Hybridoma  Bank),  anti-F4/80  (AbD   
Serotec), antiphospho-p38 (Cell Signaling Technology), antiphospho–c-Jun 
(Santa Cruz Biotechnology, Inc.), anti-MyoD (5.8A; Dako), and anti– 
Ki-67 (Abcam). Labeling of cryosections with mouse monoclonal primary 
antibodies was performed using the peroxidase or fluorescein staining 
kit (Mouse on Mouse; Vector Laboratories) according to the manufacturer’s 
instructions.  Double  immunostaining  was  performed  with  sequential   
addition of each primary and secondary antibody using appropriate 
positive and negative controls. Sections were air dried, kept unfixed 
(Pax7 and eMHC) or fixed on PFA 2–4%, washed on PBS, and incu-
bated with primary antibodies according to manufacturer’s instructions 
after blocking for 1 h at room temperature with a high protein-containing 
solution  on  PBS  (Vector  Laboratories).  Subsequently,  the  slides  were 
washed on PBS and incubated with appropriate secondary antibodies 
and labeling dyes. For immunofluorescence, secondary antibodies were 
coupled to Alexa Fluor 488 or Alexa Fluor 568 fluorochromes, and nu-
clei were stained with TO-PRO-3 or DAPI (Invitrogen). After washing, tis-
sue sections were mounted with Vectashield containing DAPI (Vector 
Laboratories)  or  Mowiol.  TUNEL  was  performed  as  indicated  by  the 
manufacturer (Roche).
Digital  images  were  acquired  using  an  upright  microscope 
(DMR6000B; Leica) equipped with a camera (DFC300FX; Leica) for   
immunohistochemical color pictures or a camera (ORCA-ER; Hamamatsu 
Photonics) for immunofluorescence pictures. HCX PL Fluotar 10×/0.30 
NA, 20×/0.50 NA, and 40×/0.75 NA objectives were used. Acquisi-
tion was performed using LAS AF software (Leica). Images were com-
posed and edited in Photoshop CS5 (Adobe), in which background was 
reduced using brightness and contrast adjustments applied to the whole 
image. Individual fibers were outlined, and their CSA was determined 
with the public domain image analysis software ImageJ (National Insti-
tutes of Health).
In situ hybridization of miR-21
In  situ  hybridizations  were  performed  in  10-µm  cryosections  from 
gastrocnemius  muscles  using  antisense  locked  nucleic  acid  (LNA)– 
modified oligonucleotides. LNA/DNA oligonucleotides contained LNAs 
at  eight  consecutive  centrally  located  bases  and  had  the  following 
sequences: LNA–miR-21, 5-TCAACATCAGTCTGATAAGCTA-3, and 
LNA-scrambled, 5-CATTAATGTCGGACAACTCAAT-3. In brief, the sec-
tions were dried at room temperature, followed by fixation in 4% para-
formaldehyde, and followed by treatment with 10 µg/ml proteinase   
K. Sections were then blocked with hybridization solution and incubated 
with FITC-conjugated miR-21 probes or FITC-conjugated control probes 
(Eurogentec)  with  scrambled  sequence  (Eurogentec).  The  sections   
were  washed  with  0.2×  SSC  followed  by  incubation  with  HRP- 
conjugated anti-FITC antibody (Roche) overnight. Nuclei were counter-
stained with hematoxylin.321 MKP-1–p38 controls inflammation-mediated tissue repair • Perdiguero et al.
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